Abstract
AbstractDown's syndrome (DS), a common chromosomal disease caused by chromosome 21 trisomy, is the main cause of cognitive impairment in children worldwide. Emerging evidence suggests that the microbiota–gut–brain axis plays a potential role in cognitive impairment. However, data regarding gut microbiota alterations in DS patients remain scarce, especially data from children with DS. This case–control study was conducted to explore the gut microbiota composition in Chinese DS children. Additionally, the potential association between gut microbiota and cognitive function in DS was evaluated. Microbiota communities in the feces of 15 DS subjects and 15 matched controls were investigated using high-throughput Illumina Miseq sequencing targeting the V3–V4 region of 16S rRNA gene. The relationships between gut microbiota composition and DS cognitive function scores were analyzed. The structure and richness of the gut microbiota differed between DS patients and healthy controls. The abundance of Acidaminococcaceae was decreased in DS patients. Moreover, the Kyoto Encyclopedia of Genes and Genomes analysis showed increased modules related to peptidases and pyrimidine metabolism. Overall, we confirmed that gut microbiota alterations occurred in Chinese patients with DS. Additionally, the fecal microbiota was closely related to DS cognitive impairment. Larger cohorts are needed to confirm these findings and to clarify the mechanisms involved. Elucidating these novel findings in the field of microbiota-gut-brain axis will provide a promising strategy for future studies of DS cognitive impairment.
Funder
National Natural Science Foundation of China
Peking University People’s Hospital Scientific Research Development Funds
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Developmental and Educational Psychology,General Medicine,Pediatrics, Perinatology and Child Health
Reference45 articles.
1. Gu E (2010) Effectiveness evaluation of screening of Down syndrome in China. Dissertation, Fudan University (in Chinese)
2. Ballard C, Mobley W, Hardy J, Williams G, Corbett A (2016) Dementia in Down’s syndrome. Lancet Neurol 15(6):622–636
3. Mcgrath RJ, Stransky ML, Cooley WC, Moeschler JB (2011) National profile of children with Down Syndrome: disease burden, access to care, and family impact. J Pediatr 159(4):535-540.e532
4. Wolvetang EW, Bradfield OM, Tymms M, Zavarsek S, Hertzog PJ (2003) The chromosome 21 transcription factor ETS2 transactivates the beta-APP promoter: implications for Down syndrome. Biochem Biophys Acta 1628(2):105–110
5. Perlmutter LS, Barron E, Chui HC (1990) Morphological association between microglia and senile plaque amyloid in Alzheimer’s disease. Neurosci Lett 30:673–681
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献